论文部分内容阅读
目的比较异丙托溴铵(可必特)与沐舒坦雾化治疗幼儿肺炎的临床效果。方法选取幼儿肺炎患儿100例,随机分为观察组与对照组各50例,2组患儿均接受常规抗感染治疗,在此基础上,对照组予沐舒坦雾化吸入治疗,观察组予可必特雾化吸入治疗,观察、比较2组治疗效果、体温复常时间、肺部啰音消失时间、咳嗽消失时间及住院时间等。结果观察组总有效率为96.0%,对照组总有效率为94.0%,差异无统计学意义(P>0.05);观察组肺部啰音消失时间、咳嗽消失时间及住院时间均较对照组短(P<0.05);2组体温复常时间差异无统计学意义(P>0.05)。提示可必特在保证疗效的前提下可有效改善幼儿肺炎患儿症状。结论可必特与沐舒坦雾化治疗幼儿肺炎临床疗效相近,改善患儿临床症状效果优于沐舒坦,值得临床推广应用。
Objective To compare the clinical effects of ipratropium bromide (available for special) and mucosolvan atomization in the treatment of infantile pneumonia. Methods 100 cases of children with pneumonia were randomly divided into observation group and control group, 50 cases each. Both groups received routine anti-infective therapy. On the basis of this, the control group was treated with mucosolvan inhalation, and the observation group Nebulized inhalation therapy may be necessary to observe and compare two groups of treatment, body temperature recovery time, pulmonary rales disappeared time, cough disappear time and hospital stay. Results The total effective rate was 96.0% in the observation group and 94.0% in the control group, with no significant difference (P> 0.05). The disappearance time of the pulmonary rales, disappearance of cough and hospital stay in the observation group were shorter than those in the control group (P <0.05). There was no significant difference in body temperature between two groups (P> 0.05). Tip may be especially under the premise of ensuring efficacy can effectively improve the symptoms of children with pneumonia. Conclusions Kebidin and Mu Shu Xun mist treatment of children with pneumonia clinical efficacy similar to improve the clinical symptoms of children is superior to Mucosolvan, worthy of clinical application.